Ignite Creation Date:
2024-05-06 @ 8:21 AM
Last Modification Date:
2024-10-26 @ 11:59 AM
Study NCT ID:
NCT02729025
Status:
COMPLETED
Last Update Posted:
2022-09-23
First Post:
2016-03-08
Brief Title:
Effects of Proprotein Convertase SubtilisinKexin Type 9 PCSK9 Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoproteina Lpa
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04-14
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-05
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-08
First Submit QC Date:
March 31 2016
Study First Post Date:
2016-04-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-04-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-09
Last Update Post Date:
2022-09-23
Last Update Post Date Type:
ACTUAL